Lilly is first drugmaker to reach $1 trillion valuation

FirstWord Pharma·Nov 21

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Eli Lilly has reportedly reached a market valuation of $1 trillion, a first for a drugmaker. This milestone is attributed to demand for the company's weight-loss products by some outlets. Eli Lilly is now the first pharmaceutical company to achieve this valuation, marking a significant event in the healthcare industry.

Full coverage

Eli Lilly becomes first drugmaker to hit $1 trillion in market value

BioPharma Dive·Nov 21

Eli Lilly Stock Hits Record Highs, Becomes First Pharmaceutical Firm Worth $1 Trillion

Yahoo Finance·May 27

Eli Lilly hits $1 trillion market value, a first in health care, as Novo Nordisk tumbles

CNBC·Nov 21

Lilly becomes first drugmaker to hit $1 trillion valuation on weight-loss demand

Reuters·Nov 21

Eli Lilly Enters Uncharted Territory as Market Cap Nears $1T

BioSpace·Nov 20

Eli Lilly Becomes First Trillion-Dollar Health Company

Hematology Advisor·Dec 4

Eli Lilly becomes first drugmaker to reach $1 trillion valuation on weight-loss boom

Ynetnews·Nov 21

Lilly becomes first $1 trillion pharma company

Endpoints News·Nov 21

View original report at FirstWord Pharma ↗

Fetching the latest headlines…